ContraFect Corporation (CFRXQ)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 20.67 Million USD | -69.03% |
| 2021 | 66.76 Million USD | 30.61% |
| 2020 | 51.11 Million USD | 46.01% |
| 2019 | 35 Million USD | 6.5% |
| 2018 | 32.87 Million USD | -34.5% |
| 2017 | 50.18 Million USD | 33.4% |
| 2016 | 37.62 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 19.25 Million USD | -6.33% |
| 2023 Q1 | 20.55 Million USD | -0.61% |
| 2023 Q3 | 9.12 Million USD | -52.6% |
| 2022 Q1 | 56.04 Million USD | -16.06% |
| 2022 Q2 | 40.79 Million USD | -27.2% |
| 2022 Q4 | 20.67 Million USD | -10.22% |
| 2022 Q3 | 23.03 Million USD | -43.54% |
| 2021 Q3 | 77.84 Million USD | 0.0% |
| 2021 Q4 | 66.76 Million USD | -14.23% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 2310.00 USD | -895094.805% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -956.027% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -95.935% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -3645.381% |
| Rebus Holdings, Inc. | 5000.00 USD | -413480.0% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 84.119% |
| Qrons Inc. | 420.00 USD | -4923471.429% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -2583.34% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 25.998% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -4203.132% |
| Skye Bioscience, Inc. | 11.94 Million USD | -73.185% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 46.768% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -186.422% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -26983.06% |
| SQZ Biotechnologies Company | 107.18 Million USD | 80.708% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -1344.032% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -28475.969% |
| Mesoblast Limited | 667.9 Million USD | 96.904% |
| Marizyme, Inc. | 22.01 Million USD | 6.069% |
| Genus plc | 1.02 Billion USD | 97.99% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -1422.358% |
| Pharming Group N.V. | 462.85 Million USD | 95.532% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -524.175% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -4043.764% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -3198.086% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -5197.336% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -5310.844% |
| IMV Inc. | 31.33 Million USD | 34.004% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -398.767% |
| MultiCell Technologies, Inc. | 126.22 USD | -16383199.002% |
| ONE Bio Corp. | 70.08 Million USD | 70.495% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -2100.622% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 83.909% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -4689.977% |
| Q BioMed Inc. | 3.51 Million USD | -488.221% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 41.218% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -7814.589% |
| Biomind Labs Inc. | 73.81 Thousand USD | -27913.113% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 95.367% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -1327.277% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 31.104% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -652.967% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -2907.916% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -694.37% |
| GB Sciences, Inc. | 103.44 Thousand USD | -19890.913% |
| Alpha Cognition Inc. | 2.45 Million USD | -743.294% |
| HST Global, Inc. | 1526.00 USD | -1355011.402% |
| CSL Limited | 38.02 Billion USD | 99.946% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -1993.086% |
| Halberd Corporation | 10.13 Thousand USD | -204016.079% |
| Enzolytics Inc. | 361.7 Million USD | 94.283% |
| Agentix Corp. | 261.39 Thousand USD | -7811.107% |
| Resverlogix Corp. | 8.11 Million USD | -154.824% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -1001.189% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.545% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 56.65% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -3132.831% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -90673.013% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -131.072% |
| AVAX Technologies, Inc. | 7.37 Million USD | -180.311% |
| Zenith Capital Corp. | 7410.00 USD | -278968.826% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.389% |
| Ember Therapeutics, Inc. | 184.00 USD | -11238486.957% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -6325.921% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -7811.954% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -2128.434% |
| Kadimastem Ltd | 2.3 Million USD | -797.495% |
| Helix BioMedix, Inc. | 3.02 Million USD | -583.584% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 60.762% |
| BioStem Technologies, Inc. | 14.56 Million USD | -42.023% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -36119.217% |
| LadRx Corporation | 2.3 Million USD | -796.016% |
| Cell Source, Inc. | 195.17 Thousand USD | -10495.324% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -5747.852% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -5747.852% |
| NovAccess Global Inc. | 62.24 Thousand USD | -33120.344% |
| Affymax, Inc. | 7.44 Million USD | -177.832% |
| Itoco Inc. | 1.4 Million USD | -1376.995% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -21517.864% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -19408.491% |
| Mobile Lads Corp. | 52.00 USD | -39767207.692% |
| CytoDyn Inc. | 11.13 Million USD | -85.695% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -14363.671% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -115554.362% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -5264.606% |
| SYBLEU INC | 330.46 Thousand USD | -6157.489% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -4950.779% |
| International Stem Cell Corporation | 5.39 Million USD | -283.655% |
| Bioxytran, Inc. | 137.63 Thousand USD | -14924.194% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -37.843% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -24.73% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -26075.949% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -2291.529% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -175.096% |
| Neutra Corp. | 2851.00 USD | -725224.448% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 36.188% |
| PureTech Health plc | 693.97 Million USD | 97.02% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -156.211% |
| IXICO plc | 15.84 Million USD | -30.517% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -149.686% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 79.986% |
| CSL Limited | 38.02 Billion USD | 99.946% |
| Cellectis S.A. | 333.99 Million USD | 93.809% |